Recombinant Geobacter uraniireducens Ferrochelatase (hemH)

Shipped with Ice Packs
In Stock

Description

Definition and Biological Role

Recombinant Geobacter uraniireducens ferrochelatase (hemH) is an engineered form of the enzyme responsible for catalyzing the final step in heme biosynthesis: the insertion of ferrous iron (Fe²⁺) into protoporphyrin IX to form protoheme IX (heme) . This metalloenzyme is critical for cellular respiration, electron transport, and the function of heme-binding proteins.

Biochemical Characteristics

Ferrochelatase in G. uraniireducens shares functional similarities with homologs in other bacteria, including:

  • Catalytic activity: Requires Fe²⁺ and protoporphyrin IX as substrates.

  • Cofactors: May utilize [2Fe-2S] clusters for structural stability, as observed in other bacterial ferrochelatases .

  • Optimal conditions: Likely operates under mesophilic conditions (32°C) and neutral pH (6.5–7.0), consistent with G. uraniireducens’s native habitat .

Table 1: Key Properties of Ferrochelatase (hemH)

PropertyDetail
Gene locushemH (specific locus not fully characterized for G. uraniireducens)
Molecular weight~40–45 kDa (estimated from homologs)
EC numberEC 4.99.1.1
Subcellular localizationCytoplasmic or membrane-associated

Table 2: Optimization Parameters for Recombinant Ferrochelatase

ParameterEffect on Yield/ActivitySource
δ-ALA supplementation↑ Heme biosynthesis (up to 100% incorporation)
Co-expression with FC↑ Holo-protein stability and homogeneity
Iron availabilityCritical for catalytic activity; Fe²⁺ preferred over Fe³⁺

Functional Insights from Related Systems

  • Heme-protein interactions: Ferrochelatase ensures complete heme incorporation into recombinant proteins, as demonstrated for G. stearothermophilus nitric oxide synthase (gsNOS). SDS-PAGE analysis revealed a single band for holo-gsNOS when co-expressed with ferrochelatase, versus multiple bands without co-expression .

  • Resonance Raman spectroscopy: Confirmed the absence of residual protoporphyrin IX contamination in ferrochelatase-co-expressed systems, indicating high-fidelity heme insertion .

Applications in Bioremediation and Biotechnology

Although G. uraniireducens ferrochelatase has not been explicitly studied, its role in heme biosynthesis is indirectly linked to the organism’s environmental applications:

  • Electron transport: Heme-containing cytochromes in G. uraniireducens mediate extracellular electron transfer (EET) to Fe(III) oxides and uranium, critical for bioremediation .

  • Bioremediation potential: Recombinant ferrochelatase could enhance the production of functional cytochromes, improving EET efficiency during uranium/arsenic detoxification .

Research Gaps and Future Directions

  • Structural characterization: No crystal structures or kinetic data exist for G. uraniireducens ferrochelatase. Comparative studies with homologs (e.g., Campylobacter jejuni HemH) are needed .

  • Metabolic engineering: Optimizing hemH expression in heterologous hosts (e.g., E. coli) could enable scalable production of heme-bound proteins for industrial use.

Product Specs

Form
Lyophilized powder. We will ship the in-stock format by default. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. All proteins ship with standard blue ice packs. Requesting dry ice will incur extra fees and requires advance notice.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
hemH; Gura_0173Ferrochelatase; EC 4.99.1.1; Heme synthase; Protoheme ferro-lyase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-319
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Geobacter uraniireducens (strain Rf4) (Geobacter uraniumreducens)
Target Names
hemH
Target Protein Sequence
MPEKTAVLLL QMGGPDSIEA VEPFLLNLFS DREIIKIGPA FLQPFIARRI CRKRAPKVEG YYSQIGGKSP IRELTEAQAQ ALEEKLGGNF RCFVAMRYWK PTTIDALAAI KREGISRVIA LSLYPHYSRA TTGSSINELK RVLGEAGARF EVSYVDRFYD HPLYIAALAA KIEEGLAQFS NRSEVELVFS AHSLPQSFID EGDPYLSHIL ETVRLVMERL GNVNYHLAFQ SRAGPVKWLE PSTEEMIQKL AKGGCKELLM VPLSFVSDHI ETLYEIDIQY AEEAKGLGIE HFRRSPSLNT SPLFIDCLAN LVHKTVSSE
Uniprot No.

Target Background

Function
Catalyzes ferrous insertion into protoporphyrin IX.
Database Links
Protein Families
Ferrochelatase family
Subcellular Location
Cytoplasm.

Q&A

What is the role of Ferrochelatase (hemH) in Geobacter uraniireducens metabolism?

Ferrochelatase (hemH) catalyzes the terminal step in heme biosynthesis by inserting ferrous iron into protoporphyrin IX to form protoheme IX (heme b). In G. uraniireducens, this enzyme plays a crucial role in the synthesis of c-type cytochromes that are essential for the organism's extracellular electron transfer capabilities. G. uraniireducens expresses different outer membrane c-type cytochromes when reducing different electron acceptors, which underscores the importance of ferrochelatase in supporting these specialized respiratory processes .

To investigate ferrochelatase function in G. uraniireducens, researchers should employ gene knockout or knockdown approaches followed by comprehensive phenotypic characterization. Focus particularly on quantifying cytochrome production through heme-stained SDS-PAGE (as demonstrated in Figure 5 of published literature) and measuring electron transfer capabilities using chronoamperometry or iron reduction assays. The appearance of distinct cytochrome bands at different molecular weights can provide insights into how ferrochelatase activity influences the organism's electron transfer proteins.

How does G. uraniireducens' electron transfer system influence experimental design when studying its ferrochelatase?

Unlike other Geobacter species that utilize conductive pili for extracellular electron transfer, G. uraniireducens possesses non-conductive pili and instead relies heavily on riboflavin-mediated electron transfer mechanisms . This unique characteristic necessitates specific methodological considerations when studying its ferrochelatase.

When designing experiments with G. uraniireducens ferrochelatase, researchers should:

  • Monitor riboflavin levels in parallel with ferrochelatase activity, as G. uraniireducens secretes significantly higher concentrations of riboflavin (up to 270 nM) compared to related species like G. sulfurreducens (70 nM) .

  • Establish growth conditions that reflect the electron acceptors typically utilized by G. uraniireducens, noting that the organism employs different modes of extracellular electron transfer depending on the acceptor (free riboflavin for Fe(III) oxide reduction versus bound riboflavin-cytochrome interactions for electrode reduction) .

  • Incorporate both Fe(III) oxide reduction assays and electrode-based measurements to comprehensively assess how ferrochelatase activity influences these distinct electron transfer pathways.

  • Consider the potential regulatory relationships between heme biosynthesis and riboflavin secretion pathways, as both processes are critical for the organism's respiratory capabilities.

What are the optimal conditions for measuring recombinant G. uraniireducens ferrochelatase activity in vitro?

For accurate measurement of recombinant G. uraniireducens ferrochelatase activity in vitro, researchers should establish conditions that reflect the organism's native environment while optimizing for enzyme stability and detection sensitivity.

The following table outlines recommended assay conditions:

ParameterRecommended RangeRationale
pH7.8-8.2Optimal range for most bacterial ferrochelatases
Temperature30°CMatches G. uraniireducens growth conditions
AtmosphereAnaerobic (<0.1% O₂)G. uraniireducens is a strict anaerobe
Reducing agent2-5 mM DTTMaintains enzyme in reduced state
Protoporphyrin IX2-10 μMBelow solubility limit in aqueous buffers
Fe²⁺ sourceFerrous ammonium sulfateProvides bioavailable iron
Buffer50-100 mM Tris-HClMaintains pH stability
Detection methodFluorescence decrease (excitation 405 nm)Measures substrate consumption

Activity measurements should be performed in an anaerobic chamber or using sealed cuvettes with oxygen-scavenging systems, reflecting G. uraniireducens' strict anaerobic nature. For kinetic analyses, consider using both iron and zinc as potential metal substrates, as zinc protoporphyrin formation often provides more stable measurements due to its fluorescence properties.

How can ferrochelatase activity be reliably quantified in G. uraniireducens cell extracts?

Quantifying ferrochelatase activity in G. uraniireducens cell extracts presents several methodological challenges due to the organism's complex redox biochemistry and the potential interference from its robust electron transfer systems.

A comprehensive protocol should include:

  • Cell lysis under strictly anaerobic conditions using a buffer containing 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10% glycerol, and 5 mM DTT to preserve enzyme activity.

  • Membrane fraction separation through ultracentrifugation, as bacterial ferrochelatases are often membrane-associated.

  • Activity measurement using either:

    • Spectrophotometric assay: Monitor the decrease in protoporphyrin IX absorbance at 408 nm

    • Fluorometric assay: Measure the formation of zinc-protoporphyrin (more sensitive)

    • HPLC analysis: For complex samples with potential interfering compounds

  • Internal standardization using known quantities of recombinant enzyme to create a calibration curve.

  • Control reactions including heat-inactivated extracts and reactions with specific ferrochelatase inhibitors like N-methylprotoporphyrin.

When analyzing results, researchers should account for the potential impact of native c-type cytochromes and riboflavin in the extracts, as these can influence the spectroscopic measurements. G. uraniireducens expresses different cytochrome patterns depending on growth conditions , which could affect baseline measurements.

How might G. uraniireducens ferrochelatase be involved in the organism's uranium reduction capabilities?

G. uraniireducens demonstrates significant uranium reduction capabilities, with hexavalent uranium (U(VI)) being precipitated primarily along conductive pili and to a lesser extent on outer membrane redox-active foci . The potential involvement of ferrochelatase in this process represents an intriguing research question that connects heme biosynthesis with uranium bioremediation applications.

The relationship can be investigated through several methodological approaches:

  • Gene expression analysis comparing ferrochelatase (hemH) transcript levels between uranium-reducing and non-reducing conditions, potentially revealing coordinated regulation with genes involved in uranium reduction.

  • Creation of controlled ferrochelatase expression mutants to assess uranium reduction capabilities. X-ray absorption spectroscopy can be employed to analyze uranium speciation and determine if altered ferrochelatase activity affects the formation of mononuclear tetravalent uranium (U(IV)) complexes that were observed in previous studies .

  • Investigation of cytochrome maturation and localization in relation to sites of uranium precipitation, as search results indicate that "uranium preferentially precipitated along the pili and, to a lesser extent, on outer membrane redox-active foci" .

  • Examination of iron homeostasis mechanisms, considering that ferrochelatase utilizes iron as a substrate and may compete with uranium reduction processes for metal cofactors.

The observation that "pili expression significantly enhanced the rate and extent of uranium immobilization per cell and prevented periplasmic mineralization" suggests that understanding the relationship between ferrochelatase, cytochrome production, and pili function could provide valuable insights into optimizing uranium bioremediation applications.

What structural adaptations might G. uraniireducens ferrochelatase possess for functioning in an organism with high riboflavin secretion?

The exceptional riboflavin secretion capability of G. uraniireducens (up to 270 nM, significantly higher than G. sulfurreducens at 70 nM) raises questions about potential structural adaptations in its ferrochelatase enzyme that might accommodate this metabolic characteristic.

A comprehensive investigation would include:

  • Comparative structural analysis with ferrochelatases from related species, focusing on:

    • Potential regulatory domains that might respond to cellular redox state

    • Surface charge distributions that could interact with riboflavin or its precursors

    • Metal-binding site architecture that might be optimized for competition with riboflavin synthesis

  • Recombinant expression and purification of G. uraniireducens ferrochelatase followed by:

    • Crystallographic studies with and without riboflavin or its derivatives

    • Circular dichroism spectroscopy to assess structural changes in response to riboflavin

    • Isothermal titration calorimetry to quantify potential binding interactions

  • Site-directed mutagenesis of:

    • Conserved catalytic residues to compare with other bacterial ferrochelatases

    • Unique residues identified through sequence alignment

    • Potential regulatory regions that might respond to riboflavin levels

The distinct modes of riboflavin utilization by G. uraniireducens (free riboflavin for Fe(III) oxide reduction versus bound riboflavin for electrode reduction) suggest that ferrochelatase might have evolved structural features to function optimally in this dual-mode electron transfer system.

How can differential cytochrome expression in G. uraniireducens inform studies of its ferrochelatase regulation?

Research has demonstrated that "G. uraniireducens expresses different outer membrane c-type cytochromes when it reduces different electron acceptors" , providing an opportunity to investigate the regulatory relationship between ferrochelatase activity and cytochrome expression patterns.

Methodological approaches to elucidate this relationship include:

  • Comparative proteomics analysis:

    • Isolate membrane fractions from G. uraniireducens grown with different electron acceptors

    • Quantify cytochrome content through heme-stained SDS-PAGE (as shown in Figure 5 from the literature)

    • Measure corresponding ferrochelatase activity levels

    • Identify co-regulated proteins that might function in coordinating heme synthesis with cytochrome expression

  • Transcriptional analysis using RNA-seq:

    • Compare transcriptome profiles under different electron acceptor conditions

    • Analyze co-expression patterns between ferrochelatase genes and cytochrome genes

    • Identify potential transcription factors that might coordinate these processes

  • ChIP-seq analysis targeting potential regulatory proteins that bind to both ferrochelatase and cytochrome gene promoters.

This integrated approach could reveal regulatory mechanisms that coordinate heme biosynthesis through ferrochelatase with the differential cytochrome expression observed when G. uraniireducens utilizes different electron acceptors .

What are the kinetic differences in electron flux through ferrochelatase-dependent pathways when G. uraniireducens uses different electron acceptors?

G. uraniireducens employs distinct electron transfer mechanisms depending on the terminal electron acceptor: free riboflavin acts as an electron shuttle for Fe(III) oxide reduction, while bound riboflavin functions as a cofactor for cytochromes during electrode reduction . These differences likely influence the kinetics of ferrochelatase-dependent pathways.

To investigate these kinetic differences, researchers should:

  • Implement isotope labeling experiments:

    • Use 57Fe and 15N-labeled precursors to track heme synthesis rates

    • Measure incorporation rates into different cytochrome fractions

    • Correlate with electron transfer rates to different acceptors

  • Employ real-time monitoring systems:

    • Chronoamperometry for electrode reduction kinetics

    • Spectroscopic monitoring of Fe(III) reduction rates

    • Fluorescence-based assays to track riboflavin redox state changes

  • Develop a comparative analysis framework:

Electron AcceptorElectron Transfer ModeMeasured ParametersExpected Ferrochelatase Demand
Fe(III) oxideFree riboflavin shuttleFe(II) production rate (0.78 mM·day−1) Baseline
Fe(III) oxide + riboflavinEnhanced shuttle mechanismFe(II) production rate (1.54 mM·day−1) Potentially lower
ElectrodeBound riboflavin-cytochromeRedox peak current at −176 mV Potentially higher
Ferrihydrite beadsDiffusion-limited shuttleFe(II) production in isolated system Intermediate

The observation that Fe(III) oxide reduction rates doubled from 0.78 mM·day−1 to 1.54 mM·day−1 when additional riboflavin was provided suggests that understanding the kinetic relationship between ferrochelatase activity and riboflavin-mediated electron transfer could provide insights into rate-limiting steps in these processes.

How can researchers design experiments to investigate the relationship between heme synthesis and riboflavin secretion in G. uraniireducens?

The dual role of riboflavin in G. uraniireducens' electron transfer strategies raises questions about potential regulatory relationships between heme biosynthesis (via ferrochelatase) and riboflavin secretion pathways. A systematic experimental design to investigate this relationship should include:

  • Genetic manipulation strategies:

    • Construct ferrochelatase knockdown strains with inducible control elements

    • Develop riboflavin synthesis pathway mutants

    • Create dual fluorescent reporter systems to monitor both processes simultaneously

  • Analytical measurement techniques:

    • Quantify riboflavin using fluorescence spectrophotometry with excitation at 440 nm and emission at 520 nm, as demonstrated in Figures 1A and 1B of previous studies

    • Measure ferrochelatase activity through zinc-protoporphyrin formation

    • Analyze cytochrome content through heme-stained SDS-PAGE as shown in Figure 5 of the literature

  • Multivariate experimental design:

Variable ManipulationMeasurement ParametersExpected RelationshipAnalytical Method
Iron limitationFerrochelatase activity, riboflavin levelsPotential compensatory increase in riboflavinLC/ESI-MS for riboflavin , enzyme assay for ferrochelatase
Partial ferrochelatase inhibitionCytochrome content, riboflavin secretionIncreased riboflavin secretion if compensatoryHeme-staining, fluorescence spectroscopy
Electron acceptor variationBoth pathway activitiesDifferent regulation patternsDPV for electrode , ferrozine assay for Fe(III)
Growth phase analysisTime-course of both pathwaysPotential temporal coordinationParallel sampling and analysis

This experimental design incorporates methodologies validated in previous studies, such as the LC/ESI-MS identification of riboflavin from G. uraniireducens culture medium (shown in Figure 1C ) and the differential pulse voltammetry approach used to characterize electron transfer to electrodes (Figure 4 ).

What analytical methods are most appropriate for characterizing the interplay between ferrochelatase activity and uranium reduction in G. uraniireducens?

Investigating the relationship between ferrochelatase activity and uranium reduction in G. uraniireducens requires an integrated analytical approach that captures both enzymatic function and metal transformation processes.

The following analytical framework is recommended:

  • Uranium reduction analysis:

    • X-ray absorption spectroscopy (XAS) to determine uranium oxidation states and coordination environments, as this technique previously revealed that G. uraniireducens reduces U(VI) to mononuclear tetravalent uranium U(IV) complexed by carbon-containing ligands

    • Transmission electron microscopy with energy-dispersive X-ray spectroscopy to localize uranium precipitates relative to cellular structures

    • Inductively coupled plasma mass spectrometry (ICP-MS) for quantitative uranium analysis

  • Ferrochelatase and heme pathway analysis:

    • Enzyme activity assays using zinc or iron as substrate

    • Liquid chromatography-mass spectrometry for porphyrin and heme quantification

    • Cytochrome content analysis through heme-stained SDS-PAGE as demonstrated for G. uraniireducens in Figure 5

  • Integrated analytical approach:

Analytical TargetMethodParameter MeasuredConnection to Previous Findings
Uranium speciationXASOxidation state, coordination"Extracellular reduction of U(VI) by the pili to mononuclear tetravalent uranium U(IV)"
Uranium localizationTEM-EDXCellular distribution"Uranium preferentially precipitated along the pili and, to a lesser extent, on outer membrane redox-active foci"
Electron transfer capacityDPVRedox peak currentRedox peak at −176 mV increases with biofilm development
Riboflavin quantificationFluorescence spectroscopyConcentration, redox stateG. uraniireducens secretes up to 270 nM riboflavin
Cytochrome profileHeme-stained SDS-PAGEExpression patternDifferent patterns based on electron acceptor

This analytical framework integrates methodologies that have successfully characterized both uranium reduction capabilities and electron transfer mechanisms in G. uraniireducens, providing a comprehensive approach to investigate the interplay between ferrochelatase activity and uranium reduction.

How can researchers differentiate between direct and indirect effects of ferrochelatase inhibition on G. uraniireducens' electron transfer capabilities?

Establishing causality between ferrochelatase activity and electron transfer processes requires carefully designed experiments that can distinguish direct effects from indirect consequences. The following methodological approach addresses this challenge:

  • Intervention strategies with appropriate controls:

    • Chemical inhibition of ferrochelatase using N-methylprotoporphyrin IX at sub-lethal concentrations

    • Genetic knockdown with inducible systems for dose-dependent effects

    • Complementation experiments with exogenous heme to bypass ferrochelatase inhibition

    • Parallel manipulation of riboflavin synthesis pathways

  • Multi-level analysis strategy:

    • Immediate biochemical consequences (porphyrin accumulation, heme depletion)

    • Short-term adaptive responses (cytochrome profile changes, riboflavin modulation)

    • Long-term physiological adaptations (electron transfer pathway remodeling)

  • Comprehensive experimental design matrix:

InterventionComplementationMeasured ParametersInterpretation Framework
Ferrochelatase inhibitorNoneEET, cytochrome content, riboflavin levelsBaseline effect of inhibition
Ferrochelatase inhibitorExogenous hemeEET, cytochrome content, riboflavin levelsDirect vs. indirect effects
Ferrochelatase inhibitorRiboflavinEET rate to ferrihydrite beadsCompensatory mechanisms
Riboflavin synthesis inhibitionNoneFe(III) reduction rate, electrode currentComparative pathway importance
Ferrochelatase inhibitorVarying electron acceptorsMode-specific effectsContext dependency of relationship

This approach builds on observations that G. uraniireducens employs two distinct modes of riboflavin-mediated electron transfer: free riboflavin shuttles for Fe(III) oxide reduction and bound riboflavin for electrode reduction . By measuring parameters specific to each mode, researchers can determine how ferrochelatase inhibition differentially affects these pathways.

What approaches can be used to investigate the potential co-regulation of ferrochelatase and riboflavin synthesis genes in G. uraniireducens?

The genome of G. uraniireducens contains "integral flavin synthesis genes coordinating 2539702 to 2543699" , providing an opportunity to investigate potential co-regulation with ferrochelatase genes. A comprehensive investigation would include:

  • Genomic context analysis:

    • Operon structure determination for both pathways

    • Promoter region analysis for shared regulatory elements

    • Identification of potential transcription factor binding sites

  • Transcriptional regulation investigation:

    • RNA-seq under varying electron acceptor and iron availability conditions

    • Quantitative RT-PCR to validate co-expression patterns

    • Chromatin immunoprecipitation (ChIP) to identify shared regulatory proteins

  • Protein-level coordination analysis:

    • Proteomic profiling across growth conditions

    • Post-translational modification analysis, particularly in response to redox changes

    • Protein-protein interaction studies to identify potential complex formation

  • Systematic experimental approach:

Investigation LevelTechniqueTargetExpected Insight
Genome organizationComparative genomicsGene cluster analysisEvolutionary conservation of co-regulation
Transcriptional activityRNA-seq, RT-qPCRExpression correlationCoordinated expression patterns
Protein abundanceProteomics, Western blotEnzyme levelsPost-transcriptional coordination
Metabolic interactionMetabolomicsPathway intermediatesMetabolic crosstalk between pathways
Regulatory networksChIP-seq, DNA affinity purificationShared regulatorsCommon regulatory mechanisms

This methodological framework would help determine whether the observed phenomena—G. uraniireducens' ability to secrete abundant riboflavin (up to 270 nM) and express different cytochrome patterns depending on electron acceptors —involve coordinated regulation with heme biosynthesis through ferrochelatase.

How should researchers interpret changes in G. uraniireducens ferrochelatase activity in the context of its dual riboflavin-mediated electron transfer systems?

The interpretation of ferrochelatase activity changes in G. uraniireducens must consider the organism's dual modes of riboflavin-mediated electron transfer: free riboflavin shuttles for Fe(III) oxide reduction and bound riboflavin-cytochrome interactions for electrode reduction .

A context-dependent interpretation framework should include:

  • Integration of multiple parameters:

    • Cytochrome content measured by heme-stained SDS-PAGE (as in Figure 5 )

    • Riboflavin concentration quantified by fluorescence spectrophotometry

    • Electron transfer rates measured by reduction assays or chronoamperometry

    • Redox peak characteristics from differential pulse voltammetry

  • Mode-specific analysis framework:

  • Data correlation approach:

    • Compare ferrochelatase activity with the redox peak current at −176 mV, which has been shown to increase with biofilm development and correlate with current production

    • Analyze against the free riboflavin peak at −235 mV for context

    • Evaluate in relation to Fe(III) oxide reduction rates under various conditions

This interpretation framework builds on the observation that "riboflavin acted as cofactors of cytochromes to promote current production in G. uraniireducens when an anode was the electron acceptor" while functioning as a free shuttle for Fe(III) oxide reduction .

What statistical approaches are most appropriate for analyzing the relationship between ferrochelatase expression and uranium reduction efficiency?

Investigating the relationship between ferrochelatase expression and uranium reduction capabilities in G. uraniireducens requires robust statistical approaches that can account for the complexity of biological systems and potential confounding factors.

The following statistical framework is recommended:

  • Correlation and regression analyses:

    • Pearson or Spearman correlation to assess the strength of relationship between ferrochelatase expression/activity and uranium reduction rates

    • Multiple regression including cytochrome content as a mediating variable, given that "uranium preferentially precipitated along the pili and, to a lesser extent, on outer membrane redox-active foci"

    • Time-series analysis to capture temporal dynamics, especially during growth phases

  • Experimental design considerations:

    • Factorial design varying ferrochelatase expression and uranium concentration

    • Repeated measures design for tracking changes over time

    • Control groups with supplemented heme to bypass ferrochelatase requirement

  • Advanced statistical modeling approaches:

Statistical ApproachApplication ScenarioAdvantageData Requirements
Path analysisModeling direct and indirect effectsDistinguishes mediated relationshipsComplete dataset with all pathway components
Mixed-effects modelsExperiments with biological replicatesAccounts for random variation between replicatesHierarchical data structure
Principal component analysisComplex datasets with multiple variablesReduces dimensionality, identifies patternsMultivariate measurements across conditions
Structural equation modelingComplex causal pathwaysTests multiple hypothesized relationships simultaneouslyComprehensive measurements of all model components

The analysis should consider that "pili expression significantly enhanced the rate and extent of uranium immobilization per cell" , suggesting that statistical models should account for the relationship between ferrochelatase, cytochrome production, and pili function in uranium reduction.

How can researchers reconcile contradictory findings between in vitro ferrochelatase activity and in vivo electron transfer performance in G. uraniireducens?

Discrepancies between isolated enzyme behavior and whole-cell performance are common challenges in enzyme research. For G. uraniireducens ferrochelatase, the following methodological approach can help reconcile such contradictions:

  • Systematic troubleshooting framework:

    • Verify enzyme stability under experimental conditions

    • Assess cofactor and substrate availability differences between in vitro and in vivo environments

    • Examine regulatory mechanisms present in cells but absent in purified systems

    • Consider structural associations with membranes or other cellular components

  • Bridging experimental approaches:

System ComplexityExperimental ApproachParameters to MeasureReconciliation Value
Purified enzymeDefined substrates, controlled conditionsKinetic parameters, substrate specificityBaseline enzymatic capabilities
Membrane fractionsPartial cellular contextActivity with native membrane componentsIdentifies membrane-associated factors
Cell lysatesComplex but disrupted systemActivity with native cofactors and regulatorsIdentifies soluble cellular factors
Permeabilized cellsNear-native environmentActivity with cellular architecture intactClosest approximation to in vivo conditions
Intact cellsComplete systemEnd-point measurements (e.g., cytochrome content)True biological outcome
  • Methodological reconciliation techniques:

    • Introduce cellular components sequentially to purified enzyme systems

    • Develop proteoliposome reconstructions that mimic membrane environments

    • Use genetic approaches to manipulate specific factors in vivo

    • Apply computational modeling to predict missing factors

This approach acknowledges that G. uraniireducens employs context-dependent electron transfer mechanisms, with "different existing modes of extracellular riboflavin" depending on the electron acceptor , which could influence ferrochelatase function differently in various experimental systems.

What bioinformatic approaches can reveal the evolutionary adaptations of G. uraniireducens ferrochelatase in the context of its unique electron transfer mechanisms?

Understanding the evolutionary adaptations of G. uraniireducens ferrochelatase requires integrated bioinformatic analyses that consider both the enzyme itself and its broader genomic and metabolic context.

A comprehensive bioinformatic investigation would include:

  • Sequence-level analyses:

    • Multiple sequence alignment with ferrochelatases from diverse bacteria, particularly other Geobacter species

    • Phylogenetic analysis to determine evolutionary relationships

    • Selection pressure analysis to identify conserved vs. rapidly evolving regions

    • Identification of unique sequence motifs that might relate to G. uraniireducens' distinct electron transfer strategies

  • Structural bioinformatics:

    • Homology modeling based on crystallized bacterial ferrochelatases

    • Molecular docking with substrates and potential regulatory molecules like riboflavin

    • Molecular dynamics simulations under different redox conditions

    • Prediction of protein-protein interaction sites, especially with cytochromes

  • Genomic context analysis:

    • Operon structure examination around the hemH gene

    • Comparative genomics with other Geobacter species that use different electron transfer modes

    • Analysis of potential regulatory relationships with the "integral flavin synthesis genes coordinating 2539702 to 2543699 in the genome of G. uraniireducens"

  • Integrated bioinformatic framework:

Analysis LevelBioinformatic ApproachResearch QuestionPotential Insight
SequenceSelection analysis, conserved motif identificationEvolutionary pressure on ferrochelataseAdaptation to high-riboflavin environment
StructureHomology modeling, binding site analysisStructural adaptations for functionPotential interactions with riboflavin
Genomic contextSynteny analysis, promoter comparisonCo-evolution with electron transfer componentsCoordinated adaptation of pathways
Metabolic integrationPathway reconstruction, flux analysisIntegration with riboflavin and cytochrome pathwaysSystem-level adaptations

This bioinformatic approach could reveal whether G. uraniireducens ferrochelatase has evolved specific adaptations to support the organism's unique electron transfer capabilities, including its high riboflavin secretion (up to 270 nM) and its ability to reduce uranium extracellularly .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.